SCHEMBL484512

SCHEMBL484512

Cn1nnc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc5c(c3)C(NC(=O)c3c(F)cccc3Cl)CC5)C4)ccc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.37
CYP3A4 P08684 7/20 0.37
CYP1A2 P05177 5/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 3/20 0.37
HSD11B1 P28845 1/20 0.37
MAPK1 P28482 1/20 0.37
HPGD P15428 5/20 0.36
USP2 O75604 4/20 0.36
ALDH1A1 P00352 2/20 0.36
ACKR3 P25106 1/20 0.36
CDK9 P50750 1/20 0.35
BDKRB1 P46663 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
RAB9A P51151 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485010 0.93 HSD11B1 (0.37) HSD11B1HPGDALDH1A1ACKR3CDK9
SCHEMBL2819857 0.90 HSD11B1 (0.39) HSD11B1HPGDALDH1A1ACKR3CDK9
SCHEMBL485147 0.89 HSD11B1 (0.36) HSD11B1HPGDACKR3CDK9BDKRB1
SCHEMBL484843 0.89 CYP2D6 (0.41) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL485145 0.86 HSD11B1 (0.40) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL2817961 0.85 MRGPRX4 (0.37) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL484545 0.85 CCR3 (0.42) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL485374 0.85 CHRM2 (0.38) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL484363 0.84 CYP3A4 (0.53) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL484966 0.84 ALPI (0.39) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP1A2 3400/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP1A2 3400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.